Desensitization Protocols for Anti-SARS-CoV-2 Vaccines in Patients with High Risk of Allergic Reactions
Vaccines for SAR-CoV-2 are the most effective preventive treatment able to reduce the risk of contracting the infection and experiencing worse outcomes whenever the infection is contracted. Despite their rarity, hypersensitivity reactions to the anti-SARS-CoV-2 vaccine have been described and could...
Main Authors: | Maria Rita Messina, Carlotta Crisciotti, Laura Pellegrini, Emanuele Nappi, Francesca Racca, Giovanni Costanzo, Lorenzo Del Moro, Sebastian Ferri, Francesca Puggioni, Giorgio Walter Canonica, Enrico Heffler, Giovanni Paoletti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-04-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/11/5/910 |
Similar Items
-
Polyethylene Glycol and Polysorbate 80 Skin Tests in the Context of an Allergic Risk Assessment for Hypersensitivity Reactions to Anti-SARS-CoV-2 mRNA Vaccines
by: Emanuele Nappi, et al.
Published: (2023-04-01) -
A randomized, pilot trial comparing full versus escalating dose regimens for the desensitization of AIDS patients allergic to sulfonamides
by: Andrea Straatmann, et al. -
Desensitization with DTP (diphtheria, tetanus and pertussis) vaccine
by: Atanasković-Marković Marina, et al.
Published: (2003-01-01) -
The Prevalence of Immediate Hypersensitivity Reactions to the BNT162b2 mRNA Vaccine against SARS-CoV-2: Data from the Vaccination Campaign in a Large Academic Hospital
by: Giovanni Paoletti, et al.
Published: (2023-04-01) -
Case report: Insulin desensitization as the only option for managing insulin allergy in a Sudanese patient
by: Rihan Said, et al.
Published: (2023-05-01)